Peptide Reference
Vesugen
Vesugen
A synthetic tripeptide that supports vascular health and endothelial function. Part of the Russian peptide bioregulator family.
Status
research
Category
cardiovascular
Typical cost
$50-100/vial
Mechanism
Supports endothelial cell function and vascular health. Improves microcirculation and blood vessel elasticity. May support cardiovascular health through vascular optimization.
Potential benefits
- Improved vascular function
- Better microcirculation
- Endothelial support
- Cardiovascular health
Reported side effects
- Limited data
- Generally well-tolerated
Common dosing references
oral
1-2mg · Daily
4-6 weeks
Research notes
Vesugen and vascular health
2014
Demonstrated improvements in endothelial function and microcirculation
Regulatory and sourcing notes
Research chemical. Russian development. Not FDA-approved.
Research peptide. Russian bioregulator. Oral administration.
Find peptide-aware clinics
Use location pages to compare clinics with peptide therapy signals and verify clinical oversight before treatment.